Simultaneous quantification of zidovudine and its metabolites in serum and urine by high-performance liquid chromatography using a column-switching technique. 1990

C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
Département de Pharmacocinétique, Centre Hospitalier Général, Le Havre, France.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
September 1988, Journal of chromatography,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
March 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
July 1989, Biomedical chromatography : BMC,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
January 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
March 1992, Journal of forensic sciences,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
July 1983, Journal of chromatography,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
August 2001, Journal of chromatography. B, Biomedical sciences and applications,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
January 1993, Yao xue xue bao = Acta pharmaceutica Sinica,
C Lacroix, and T P Hoang, and F Wojciechowski, and H Duwoos, and J Nouveau, and B Diquet
September 2004, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!